STOCK TITAN

iRhythm collaborates with Epic to streamline access to Zio® service and drive more seamless connectivity between clinicians and patients

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
iRhythm Technologies, Inc. (NASDAQ:IRTC) partners with Epic to integrate Zio long-term continuous monitoring services into the healthcare provider's EHR platforms, aiming to improve operational efficiency and patient care. The collaboration is estimated to save organizations up to 75% of integration time, with iRhythm already having over 1.5 million registrations through EHR-integrated customers, resulting in significant cost and time savings. This strategic move positions iRhythm as the first medical device company to join the Epic community, enhancing access to Zio services for healthcare providers and patients nationwide.
Positive
  • None.
Negative
  • None.

iRhythm's collaboration with Epic to integrate Zio services into the Epic Aura platform may significantly enhance operational efficiency within healthcare organizations. By embedding a continuous cardiac monitoring solution into a widely adopted Electronic Health Record (EHR) system, iRhythm is positioned to streamline workflow for clinicians and potentially reduce the administrative burden. This integration could lead to faster adoption rates of Zio services, given the reduced time and cost of implementation, which are critical factors when health systems evaluate new technologies.

From a market perspective, the ability to save up to 75% on integration time is a compelling value proposition for healthcare providers. This efficiency gain, alongside the reported savings in staff time and costs, may contribute to a competitive advantage for iRhythm in the digital healthcare market. The mention of 1.5 million all-time registrations for Zio services indicates strong market penetration, which could be further bolstered by this initiative.

The integration of iRhythm's Zio services into the Epic EHR system has the potential to enhance patient care by providing clinicians with seamless access to longitudinal cardiac data. Such integration facilitates a more comprehensive view of a patient's cardiac health, allowing for earlier detection and treatment of arrhythmias. This is particularly important as intermittent arrhythmias can be difficult to diagnose with one-off tests. The availability of continuous monitoring data could lead to better outcomes for patients at risk of cardiac events.

Moreover, the collaboration with Epic may expedite research opportunities by aggregating large datasets of cardiac monitoring information. This could lead to advancements in the understanding of arrhythmias and the development of predictive analytics for proactive patient monitoring, ultimately contributing to the field of precision medicine.

The strategic partnership between iRhythm and Epic can be seen as a reflection of broader trends in the healthcare industry towards interoperability and data integration. The focus on EHR integration is in line with the industry's push for a more connected health grid, which aims to facilitate seamless information flow and improve patient outcomes. The mention of Epic's 250 million patient records underscores the scale at which iRhythm's Zio services could be deployed, potentially affecting a vast patient population.

As the first medical device company to join the Epic community, iRhythm may set a precedent for similar collaborations in the future. This move could encourage other medical device companies to pursue EHR integrations, further expanding the health grid and prompting a shift towards more collaborative and data-driven healthcare ecosystems.

  • iRhythm is the first medical device company to join the Epic community, using Aura to drive efficiencies through EHR integration
  • The collaboration will expand access to Zio service across the continuum of patient care—from cardiology to primary care to emergency departments and beyond1

SAN FRANCISCO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare company focused on creating trusted solutions that detect, predict, and prevent disease, today announced it will use Epic’s Aura platform to streamline access to iRhythm’s Zio long-term continuous monitoring and ambulatory mobile cardiac telemetry services ("Zio services”) through improved operational efficiency for clinicians.

“Our work with Epic aligns with our goal to optimize clinician workflow efficiencies and provide seamless access to our Zio services. By integrating Zio services into healthcare providers' EHR platforms, we are not just simplifying operations but empowering our health system customers to devote more time to patient care,” said Quentin Blackford, president and chief executive officer of iRhythm. “We believe this integration facilitates improved patient care, ensuring that our customers and their staff can focus on what truly matters—patient health. We are committed to continuous investment in our systems and services to make healthcare more efficient, secure, and patient-focused.”

Through this collaboration, iRhythm and Epic will give healthcare organizations the ability to more efficiently implement Zio services. Through Aura, Epic’s specialty diagnostics and devices suite, we estimate that organizations can save up to 75% of the time it typically takes to integrate Zio services into their local instance of Epic software. iRhythm has already surpassed 1.5 million all-time registrations for Zio services received through EHR-integrated customers. The company estimates this has translated to hundreds of thousands of hours and millions of dollars in staff time costs saved by health systems.

“iRhythm is the first medical device manufacturer to join the Epic community—an addition that reflects the continued growth of the health grid and a more collaborative healthcare ecosystem,” said Alan Hutchison, vice president at Epic. “With longitudinal cardiac data at their fingertips, providers across care settings can more effectively identify and treat the arrhythmias that one-off tests sometimes miss. This kind of technology sets the stage for the eventual proactive monitoring of patients who are at risk for arrhythmias before their symptoms become severe.”

Through this collaboration, iRhythm’s Zio service will be more readily available to healthcare providers using Epic—and the more than 250 million patients in the U.S. who have a record in Epic.

iRhythm is partnering with early adopter customers to integrate Zio services into the Aura network across their health systems in Q4 2024, and the company expects to begin offering this solution to existing and new Zio customers starting in early 2025.

To learn more about how Zio can integrate with your Epic system, please visit Epic’s online showroom. To learn more about iRhythm, please visit https://www.irhythmtech.com/.

  1. Zio monitor, XT, and AT are contraindicated for critical care patients

About iRhythm Technologies, Inc.

iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Contact
Stephanie Zhadkevich
(919) 452-5430
investors@irhythmtech.com

Media Contact
Saige Smith
(262) 289-7065
irhythm@highwirepr.com


FAQ

What is the ticker symbol for iRhythm Technologies, Inc.?

The ticker symbol for iRhythm Technologies, Inc. is IRTC.

What is the collaboration between iRhythm and Epic focused on?

The collaboration aims to streamline access to iRhythm's Zio long-term continuous monitoring and ambulatory mobile cardiac telemetry services through improved operational efficiency for clinicians.

How many registrations has iRhythm Technologies received for Zio services through EHR-integrated customers?

iRhythm Technologies has received over 1.5 million all-time registrations for Zio services through EHR-integrated customers.

What percentage of integration time can organizations save through the collaboration between iRhythm and Epic?

Organizations can save up to 75% of the time it typically takes to integrate Zio services into their local instance of Epic software.

When will iRhythm begin offering the integrated Zio services to existing and new customers?

iRhythm expects to begin offering the integrated Zio services to existing and new customers starting in early 2025.

iRhythm Technologies, Inc

NASDAQ:IRTC

IRTC Rankings

IRTC Latest News

IRTC Stock Data

3.48B
30.66M
1.05%
109.1%
8.24%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
San Francisco

About IRTC

irhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ecg, monitoring for patients at risk for arrhythmias. we have created a unique platform, zio by irhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.